Sort
82,697 grants matching “vaccine development”
Live attenuated vaccines for pandemic preparedness
$2,680,016Medimmune Vaccines, Inc. · UC1 · FY2000 · AI
Vanderbilt HIV Clinical Trials Unit (CTU)
$2,679,601David W Haas · Vanderbilt University Medical Center · UM1 · FY2022 · AI
Center for the Study of Immune Mechanisms of Flavivirus Control
$2,679,477Michael J Gale · University Of Washington · U19 · FY2016 · AI
DEVELOPMENT OF RICIN VACCINE FORMULATION
$2,678,720Robert Brey · Soligenix, Inc. · N01 · FY2015 · AI
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$2,678,466Kenner Rice · National Institute On Drug Abuse · ZIA · FY2025 · DA
ExpLoiting thErapeutic VulnerAbilities in hepaTocEllular carcinoma (ELEVATE)
$2,678,459Devanand Sarkar · Virginia Commonwealth University · P01 · FY2024 · CA
Nonhuman Primate (NHP) Core Functional Genomics Laboratory for AIDS Vaccine Research and Development
$2,675,533Michael Gale · University Of Washington · N01 · FY2024 · AI
Immune Responses to Malaria and HIV Infection and Immunization
$2,675,440Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2018 · AI
Advanced Development of Vaccine Candidates for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases
$2,674,055Dinja Oosterhoff · Intravacc B.V. · N01 · FY2024 · AI
Preventive Vaccines for HIV
$2,673,929Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$2,670,995Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2018 · AI
Improved Anthrax Vaccine Stability &use of Adjuvants
$2,670,906Avecia Biologics, Ltd · UC1 · FY2005 · AI
DNA/MWA Immunogens, Cross-clade Immune Responses
$2,670,866Emory University · P01 · FY2004 · AI
Mucosal Immunity, Vaccines and Microbiota Interplay in Humans and Animal
$2,670,651Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2013 · AI
Center/Coordination, Analysis and Management/MACS
$2,670,224Lisa P Jacobson · Johns Hopkins University · UM1 · FY2015 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$2,669,207Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2008 · AI
Modulation of Biodefense Responses to Microbial Pathogens
$2,669,115Anthony T. Vella · University Of Connecticut Sch Of Med/Dnt · P01 · FY2016 · AI
Institute for Clinical and Translational Research
$2,668,511Daniel Ernest Ford · Johns Hopkins University · KL2 · FY2007 · RR
Infectious Diseases and Allergy Scientific Education and Outreach
$2,668,372Kathryn Zoon · National Institute Of Allergy And Infectious Diseases · ZIJ · FY2010 · AI
Modulation of Biodefense Responses to Microbial Pathogens
$2,668,025Anthony T. Vella · University Of Connecticut Sch Of Med/Dnt · P01 · FY2015 · AI
Computational Biology in Systems Immunology and Infectious Disease Modeling
$2,667,952Martin Meier-Schellersheim · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
UofL RBL Operations, Workforce Development and Pandemic Preparedness Research
$2,667,645Kenneth E Palmer · University Of Louisville · UC7 · FY2024 · AI
Modulation of Biodefense Responses to Microbial Pathogens
$2,667,494Anthony T. Vella · University Of Connecticut Sch Of Med/Dnt · P01 · FY2017 · AI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$2,667,211Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA
Influenza Viral Pathogenesis
$2,667,011Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI